Alpine Woods Capital Investors, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Alpine Woods Capital Investors, LLC

$512 Million
Q1 2024

A detailed history of Alpine Woods Capital Investors, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Alpine Woods Capital Investors, LLC holds 3,977 shares of REGN stock, worth $4.19 Million. This represents 0.75% of its overall portfolio holdings.

Number of Shares

3,977

Previous 7,478 46.82%

Holding current value

$4.19 Million

Previous $6.57 Million 41.72%

% of portfolio

0.75%

Previous 0.93%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	SELL	$902.69 - $993.35 $3.16 Million - $3.48 Million	-3,501 Reduced 46.82%	3,977 $3.83 Million
Q4 2023 Jan 24, 2024	SELL	$775.18 - $881.7 $539,525 - $613,663	-696 Reduced 8.51%	7,478 $6.57 Million
Q3 2023 Nov 08, 2023	BUY	$692.45 - $844.37 $126,025 - $153,675	182 Added 2.28%	8,174 $6.73 Million
Q2 2023 Aug 02, 2023	BUY	$700.03 - $830.35 $1.07 Million - $1.27 Million	1,530 Added 23.68%	7,992 $5.74 Million
Q1 2023 May 08, 2023	BUY	$680.49 - $826.97 $1,360 - $1,653	2 Added 0.03%	6,462 $5.31 Million

Q4 2022 Feb 08, 2023	SELL	$705.89 - $766.39 $619,065 - $672,124	-877 Reduced 11.95%	6,460 $4.66 Million
Q3 2022 Oct 31, 2022	BUY	$573.97 - $724.32 $286,985 - $362,160	500 Added 7.31%	7,337 $5.05 Million
Q2 2022 Aug 02, 2022	SELL	$548.35 - $738.84 $54,835 - $73,884	-100 Reduced 1.44%	6,837 $4.04 Million
Q4 2021 Feb 03, 2022	BUY	$543.48 - $670.97 $197,826 - $244,233	364 Added 5.54%	6,937 $4.38 Million
Q2 2021 Aug 09, 2021	SELL	$472.8 - $558.54 $119,145 - $140,752	-252 Reduced 3.69%	6,573 $3.67 Million
Q1 2021 May 11, 2021	SELL	$446.73 - $548.2 $44,673 - $54,820	-100 Reduced 1.44%	6,825 $3.23 Million
Q4 2020 Feb 01, 2021	BUY	$478.3 - $607.98 $234,367 - $297,910	490 Added 7.61%	6,925 $3.35 Million
Q3 2020 Nov 02, 2020	SELL	$544.75 - $658.21 $89,883 - $108,604	-165 Reduced 2.5%	6,435 $3.6 Million
Q2 2020 Aug 10, 2020	SELL	$493.32 - $643.92 $147,996 - $193,176	-300 Reduced 4.35%	6,600 $4.12 Million
Q1 2020 May 04, 2020	BUY	$336.18 - $494.43 $806,832 - $1.19 Million	2,400 Added 53.33%	6,900 $3.37 Million
Q4 2018 Feb 13, 2019	SELL	$335.82 - $403.04 $33,582 - $40,304	-100 Reduced 2.17%	4,500 $1.68 Million
Q3 2018 Nov 08, 2018	BUY	$351.14 - $408.51 $35,114 - $40,851	100 Added 2.22%	4,600 $1.86 Million
Q2 2018 Aug 09, 2018	BUY	$284.6 - $344.99 $426,900 - $517,485	1,500 Added 50.0%	4,500 $1.55 Million
Q4 2017 Feb 14, 2018	BUY	$358.63 - $469.95 $717,260 - $939,900	2,000 Added 200.0%	3,000 $1.13 Million
Q3 2017 Nov 08, 2017	BUY	$431.38 - $504.0 $431,380 - $504,000	1,000	1,000 $447,000

Others Institutions Holding REGN

# of Institutions

1,429

Shares Held

82.1M

Call Options Held

835K

Put Options Held

1.46M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $113B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Woods Capital Investors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Woods Capital Investors, LLC with notifications on news.

Account

Alpine Woods Capital Investors, LLC Regeneron Pharmaceuticals, Inc. Transaction History